Patent Litigation
Complex infringement and defense actions in U.S. federal courts — claim construction, validity, damages, trial, and appeal.
Kroub Kolmykov PLLC — d/b/a K2K Law — is an intellectual property boutique focused on high-stakes patent litigation, strategic patent analytics, and technology-driven monetization.
We represent patent owners, operating companies, and investors in complex disputes and advisory matters where technical depth, litigation experience, and strategic clarity are essential.
The firm is led by two founding partners, each with over 25 years of experience in patent defense and enforcement, bringing complementary backgrounds across high-technology and pharmaceutical / life-sciences matters. Every engagement receives senior-level attention and a litigation-ready, business-aligned mindset.
An integrated practice combining courtroom advocacy, claim-centric analysis, and data-driven strategy across the entire patent lifecycle.
Complex infringement and defense actions in U.S. federal courts — claim construction, validity, damages, trial, and appeal.
IPRs, PGRs, and reexaminations, closely coordinated with parallel district court litigation and portfolio objectives.
Enforcement-backed monetization, licensing program design, and patent acquisition and divestiture support.
Claim-strength scoring, portfolio prioritization, landscape mapping, and litigation-readiness analysis.
Executive- and expert-ready guidance for boards, investors, and licensing counterparties.
From pharmaceuticals and life sciences to software, wireless, semiconductors, and AI-driven systems.

IP litigator with 25+ years in patent defense and enforcement, with a strong emphasis on pharmaceutical and life-sciences disputes alongside a broad technology practice. A recognized commentator on patent law.

Highly regarded IP litigator and strategist with 25+ years of experience, focused on high-technology disputes — software, telecom, networking, electronics, and AI-enabled systems. Recognized in Super Lawyers and the IAM Strategy 300.
Tell us about your dispute, portfolio, or licensing question. All inquiries are treated as strictly confidential.